ash 2024: bijal shah, md presents on the blinatumomab ponatinib effective in ph all & cml
Published 2 hours ago • No plays • Length 1:04Download video MP4
Download video MP3
Similar videos
-
2:20
a dynamic approach to managing frail patients with multiple myeloma
-
2:12
phase ii study of acalabrutinib, venetoclax, and obinutuzumab in cll enriched for high-risk disease
-
2:21
updated results of the andromeda trial: daratumumab cybord versus cybord alone in al amyloidosis
-
3:19
the rest study: isatuximab-bortezomib-lenalidomide in elderly patients with myeloma
-
1:28
rapcabtagene autoleucel in patients with r/r dlbcl
-
1:50
driver mutations predicting clinical outcomes upon mrd-guided venetoclax plus ibrutinib in r/r cll
-
1:09:59
exploring new paradigms in comprehensive care for cardio renal metabolic diseases
-
0:20
atherosclerosis animation | atherosclerotic plaque | medical animation | lipoproteins animation
-
1:15
tagraxofusp demonstrates anti-tumor activity without myelosuppression in patients with bpdcn
-
0:10
⚽briliant goal #calcio #football#futbol#soccer #viral#omsak
-
1:01
nervio troclear (iv par craneal)